LIPELLA PHARMACEUTICALS INC (LIPO) Stock Cash Flow
NASDAQ:LIPO - Nasdaq - US53630L2097 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.13M | -5.02M | -4.62M | -2.60M | -1.87M | |||
| Depreciation Amortization | 3.50K | 2.90K | 1.70K | N/A | N/A | |||
| Change In Working Capital | 598.90K | 113.20K | -9.10K | 9.50K | 197.60K | |||
| Interest Paid | 9.90K | 11.90K | 11.40K | 0.00 | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | 540.10K | 949.40K | 1.48M | 757.00K | 678.60K | |||
| OPERATING CASH FLOW | -3.99M | -3.95M | -3.15M | -1.83M | -989.30K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | -14.40K | N/A | N/A | |||
| Other Investing Activity | N/A | 0.00 | 0.00 | 300.60K | -300.60K | |||
| INVESTING CASH FLOW | N/A | 0.00 | -14.40K | 300.60K | -300.60K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | -275.00K | 275.00K | 0.00 | |||
| Stock Issued/Repurchased | 6.11M | 2.84M | 1.61M | 4.96M | 2.10M | |||
| FINANCING CASH FLOW | 6.11M | 2.84M | 1.34M | 5.24M | 2.10M | |||
| CHANGE IN CASH | 2.12M | -1.11M | -1.83M | 3.71M | 807.10K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -3.99M | -3.95M | -3.15M | -1.83M | -989.30K | |||
| Capital Expenditure | N/A | N/A | -14.40K | N/A | N/A | |||
| FREE CASH FLOW | -3.99M | -3.95M | -3.16M | -1.83M | -989.30K | |||
All data in USD